Pub Date : 2025-04-05DOI: 10.1007/s11920-025-01607-7
Dana Steidtmann, S McBride, M Mishkind, J Shore
Purpose of review: Hybrid work is common in mental health care following the COVID-19 pandemic. Although widespread, little is known about how to optimize it. We review relevant literature for patients, employees and mental health systems, and offer guidance on navigating tradeoffs in the application of hybrid work.
Recent findings: Patients often prefer telehealth visits due to convenience, but in-person visits are sometimes clinically indicated or preferred. The mental health workforce appreciates reduced commutes and flexibility, though may risk increased isolation and work fatigue. Mental health systems may realize cost savings, although these may create challenges for accommodating patient in-person needs or employee preferences. Hybrid work in mental health care presents a promising path forward but requires thoughtful tradeoff management. It is unlikely that all benefits of hybrid work can be realized at once. Settings may benefit from identifying top priorities and designing hybrid work arrangements accordingly.
{"title":"From Couch to Click: Opportunities and Challenges of Hybrid Work Models in Mental Health Care.","authors":"Dana Steidtmann, S McBride, M Mishkind, J Shore","doi":"10.1007/s11920-025-01607-7","DOIUrl":"https://doi.org/10.1007/s11920-025-01607-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Hybrid work is common in mental health care following the COVID-19 pandemic. Although widespread, little is known about how to optimize it. We review relevant literature for patients, employees and mental health systems, and offer guidance on navigating tradeoffs in the application of hybrid work.</p><p><strong>Recent findings: </strong>Patients often prefer telehealth visits due to convenience, but in-person visits are sometimes clinically indicated or preferred. The mental health workforce appreciates reduced commutes and flexibility, though may risk increased isolation and work fatigue. Mental health systems may realize cost savings, although these may create challenges for accommodating patient in-person needs or employee preferences. Hybrid work in mental health care presents a promising path forward but requires thoughtful tradeoff management. It is unlikely that all benefits of hybrid work can be realized at once. Settings may benefit from identifying top priorities and designing hybrid work arrangements accordingly.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2025-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143787905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-03DOI: 10.1007/s11920-025-01598-5
Catherine E Roberts, Dolapo A Oseni, Bettina Bohle-Frankel, Claudia L Reardon
Purpose of review: Over 500,000 college students compete in the three divisions of the National Collegiate Athletic Association (NCAA) each year. The rates of most mental health issues among collegiate student-athletes approximate the rates among non-athlete college students. In recent years, greater attention has been given to recognizing and treating the mental health concerns of student-athletes. This paper examines some of the specific mental health considerations that may arise when working with student-athletes.
Recent findings: Using a biopsychosocial-structural framework, we were able to identify several broad categories of factors that influence the mental health of student-athletes. Within those categories we identified specific diagnoses (such as physical injury), life events (such as early retirement from sport), ways of thinking (including stigma against mental health treatment), and external influences (such as racism and sexism) that impact the mental health of student-athletes. Mental health concerns among college students are common. When working with student-athletes, there are biopsychosocial-structural factors that affect the mental health of student-athletes in unique ways compared to their non-athlete college student counterparts.
{"title":"Get your Head in the Game!: A Review of Factors that Impact Collegiate Student-Athlete Mental Health Using a Biopsychosocial-Structural Framework.","authors":"Catherine E Roberts, Dolapo A Oseni, Bettina Bohle-Frankel, Claudia L Reardon","doi":"10.1007/s11920-025-01598-5","DOIUrl":"https://doi.org/10.1007/s11920-025-01598-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>Over 500,000 college students compete in the three divisions of the National Collegiate Athletic Association (NCAA) each year. The rates of most mental health issues among collegiate student-athletes approximate the rates among non-athlete college students. In recent years, greater attention has been given to recognizing and treating the mental health concerns of student-athletes. This paper examines some of the specific mental health considerations that may arise when working with student-athletes.</p><p><strong>Recent findings: </strong>Using a biopsychosocial-structural framework, we were able to identify several broad categories of factors that influence the mental health of student-athletes. Within those categories we identified specific diagnoses (such as physical injury), life events (such as early retirement from sport), ways of thinking (including stigma against mental health treatment), and external influences (such as racism and sexism) that impact the mental health of student-athletes. Mental health concerns among college students are common. When working with student-athletes, there are biopsychosocial-structural factors that affect the mental health of student-athletes in unique ways compared to their non-athlete college student counterparts.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143771825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-02-25DOI: 10.1007/s11920-025-01591-y
Cecilia Bolling, M Elizabeth Cardoni, J Todd Arnedt
Purpose of review: Sleep disturbances are prevalent among those with comorbid substance use disorders (SUD), significantly impacting the initiation, maintenance and relapse of these conditions.
Recent findings: This review explores the latest research on the reciprocal relationship between sleep and substance misuse, the effects of treating sleep on substance use outcomes, and the potential therapeutic uses of cannabis for sleep disorders in people with and without SUDs. Understanding these interactions may be critical for augmenting current treatment strategies aimed at improving sleep disturbances and recovery outcomes in individuals with SUDs.
{"title":"Sleep and Substance Use: Exploring Reciprocal Impacts and Therapeutic Approaches.","authors":"Cecilia Bolling, M Elizabeth Cardoni, J Todd Arnedt","doi":"10.1007/s11920-025-01591-y","DOIUrl":"10.1007/s11920-025-01591-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Sleep disturbances are prevalent among those with comorbid substance use disorders (SUD), significantly impacting the initiation, maintenance and relapse of these conditions.</p><p><strong>Recent findings: </strong>This review explores the latest research on the reciprocal relationship between sleep and substance misuse, the effects of treating sleep on substance use outcomes, and the potential therapeutic uses of cannabis for sleep disorders in people with and without SUDs. Understanding these interactions may be critical for augmenting current treatment strategies aimed at improving sleep disturbances and recovery outcomes in individuals with SUDs.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":"199-205"},"PeriodicalIF":5.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143491055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-02-06DOI: 10.1007/s11920-025-01586-9
Leslie M Swanson, Jessica R Schubert, Greta B Raglan, Deirdre A Conroy
Purpose of the review: This narrative review examines the newest findings from clinical trials of chronotherapeutics for psychiatric disorders. We reviewed the potential effects of the most commonly-studied chronotherapeutics such as bright light therapy, dark therapy, melatonin, and chronotherapy on the psychiatric disorders of depression, bipolar disorder, and anxiety disorders.
Recent findings: The preponderance of recent clinical trials in chronotherapeutics has focused on bright light therapy in depression. However, there is an emerging body of preliminary studies testing chronotherapeutics in other psychiatric disorders, including bipolar disorder and post-traumatic stress disorder. Chronotherapeutics hold potential to improve sleep in adults with psychiatric conditions as well as psychiatric symptoms. Although the most recent literature demonstrates the promise of these interventions, the current body of work is limited by small sample sizes and relatively few studies outside of depression. Larger-scale trials are needed to refine treatment protocols, develop personalized treatment approaches, and inform dissemination. Studies in psychiatric conditions besides depression are particularly needed.
{"title":"Chronotherapeutic Treatments for Psychiatric Disorders: A Narrative Review of Recent Literature.","authors":"Leslie M Swanson, Jessica R Schubert, Greta B Raglan, Deirdre A Conroy","doi":"10.1007/s11920-025-01586-9","DOIUrl":"10.1007/s11920-025-01586-9","url":null,"abstract":"<p><strong>Purpose of the review: </strong>This narrative review examines the newest findings from clinical trials of chronotherapeutics for psychiatric disorders. We reviewed the potential effects of the most commonly-studied chronotherapeutics such as bright light therapy, dark therapy, melatonin, and chronotherapy on the psychiatric disorders of depression, bipolar disorder, and anxiety disorders.</p><p><strong>Recent findings: </strong>The preponderance of recent clinical trials in chronotherapeutics has focused on bright light therapy in depression. However, there is an emerging body of preliminary studies testing chronotherapeutics in other psychiatric disorders, including bipolar disorder and post-traumatic stress disorder. Chronotherapeutics hold potential to improve sleep in adults with psychiatric conditions as well as psychiatric symptoms. Although the most recent literature demonstrates the promise of these interventions, the current body of work is limited by small sample sizes and relatively few studies outside of depression. Larger-scale trials are needed to refine treatment protocols, develop personalized treatment approaches, and inform dissemination. Studies in psychiatric conditions besides depression are particularly needed.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":"161-175"},"PeriodicalIF":5.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-02-21DOI: 10.1007/s11920-025-01589-6
Martin Pastre, Stéphane Raffard, Luc Mallet, Jorge Lopez-Castroman
Purpose of review: We aimed to investigate the recent understanding of the frequent coexistence of obsessive-compulsive disorder (OCD) and major depression (MDD), exploring both clinical and mechanistic perspectives. Our focus was on deriving conclusions with therapeutic implications.
Recent findings: While biological factors contribute to the development of OCD-MDD, the comorbidity seems to be primarily induced by the convergence of symptoms that complicate the course of OCD. Tailored cognitive-behavioral therapy programs, specifically addressing MDD, alongside SSRI medication, may prove beneficial for patients experiencing moderate to severe forms of this comorbidity. The review underscores the significance of comorbidity from both diagnostic and therapeutic perspectives. However, existing research has yet to offer a clear understanding of the underlying mechanisms. Further research in the field, notably coming from network studies, could enrich our practice by helping to target specific dimensions that underly OCD-MDD comorbidity.
{"title":"The Relationship between OCD and Depression in Adults: A Review of Recent Findings.","authors":"Martin Pastre, Stéphane Raffard, Luc Mallet, Jorge Lopez-Castroman","doi":"10.1007/s11920-025-01589-6","DOIUrl":"10.1007/s11920-025-01589-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>We aimed to investigate the recent understanding of the frequent coexistence of obsessive-compulsive disorder (OCD) and major depression (MDD), exploring both clinical and mechanistic perspectives. Our focus was on deriving conclusions with therapeutic implications.</p><p><strong>Recent findings: </strong>While biological factors contribute to the development of OCD-MDD, the comorbidity seems to be primarily induced by the convergence of symptoms that complicate the course of OCD. Tailored cognitive-behavioral therapy programs, specifically addressing MDD, alongside SSRI medication, may prove beneficial for patients experiencing moderate to severe forms of this comorbidity. The review underscores the significance of comorbidity from both diagnostic and therapeutic perspectives. However, existing research has yet to offer a clear understanding of the underlying mechanisms. Further research in the field, notably coming from network studies, could enrich our practice by helping to target specific dimensions that underly OCD-MDD comorbidity.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":"187-198"},"PeriodicalIF":5.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-02-24DOI: 10.1007/s11920-025-01590-z
Grace Chang, Justine Lazatin
Purpose of review: Systematic review to identify the most promising experimental approaches to modify prenatal alcohol and cigarette use published since 2019.
Recent findings: 20 studies met review criteria. Among the five approaches to prenatal alcohol use, a study comparing brief intervention or brief advice to treatment as usual in Argentina, and a practice change intervention to include evidence-based assessment and intervention of prenatal alcohol use in Australia were noteworthy. Five different strategies to modify cigarette use included diverse samples and settings. An innovative approach that was rigorously evaluated was conducted in Hong Kong where an intervention with brief advice, a nicotine sample, and active referral to smoking cessation service resulted in doubling the odds of biochemically validated abstinence from nicotine in expectant fathers when compared to an attention control condition. Prenatal alcohol and cigarette smoking are common in the US and pending effective intervention strategies that may be informed by international research.
{"title":"Modifying the Use of Alcohol and Cigarettes in the Antepartum.","authors":"Grace Chang, Justine Lazatin","doi":"10.1007/s11920-025-01590-z","DOIUrl":"10.1007/s11920-025-01590-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Systematic review to identify the most promising experimental approaches to modify prenatal alcohol and cigarette use published since 2019.</p><p><strong>Recent findings: </strong>20 studies met review criteria. Among the five approaches to prenatal alcohol use, a study comparing brief intervention or brief advice to treatment as usual in Argentina, and a practice change intervention to include evidence-based assessment and intervention of prenatal alcohol use in Australia were noteworthy. Five different strategies to modify cigarette use included diverse samples and settings. An innovative approach that was rigorously evaluated was conducted in Hong Kong where an intervention with brief advice, a nicotine sample, and active referral to smoking cessation service resulted in doubling the odds of biochemically validated abstinence from nicotine in expectant fathers when compared to an attention control condition. Prenatal alcohol and cigarette smoking are common in the US and pending effective intervention strategies that may be informed by international research.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":"206-219"},"PeriodicalIF":5.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143490420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-03-14DOI: 10.1007/s11920-025-01587-8
Brunhild Kring, Ludmila de Faria, Alexandra Ackerman, Meera Menon, Francesco Peluso
Purpose of review: We examine the deleterious effects on emotional development and mental health of college students wrought by the COVID-19 pandemic. In the era of climate change, political polarization, and global pandemics, some students are likely exposed to public disasters either on campus or at home at any given time.
Recent findings: The worsening incidence and severity of mental health symptoms foreshadowed a youth mental health crisis of unanticipated proportions. Post disaster, the treatment of physical illness typically takes precedence to the exclusion of preventive mental health measures. Even though the mental health effects of mass trauma are more pervasive and last longer than physical symptoms, mental health experts did not have a prominent place at the table of the COVID-19 response teams beyond their traditional role in the care of individual students. We conclude with a review of best practices for psychological first aid, and highlight the need for disaster response training for psychiatrists.
{"title":"The Fallout of the COVID-19 Pandemic on College Students.","authors":"Brunhild Kring, Ludmila de Faria, Alexandra Ackerman, Meera Menon, Francesco Peluso","doi":"10.1007/s11920-025-01587-8","DOIUrl":"10.1007/s11920-025-01587-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>We examine the deleterious effects on emotional development and mental health of college students wrought by the COVID-19 pandemic. In the era of climate change, political polarization, and global pandemics, some students are likely exposed to public disasters either on campus or at home at any given time.</p><p><strong>Recent findings: </strong>The worsening incidence and severity of mental health symptoms foreshadowed a youth mental health crisis of unanticipated proportions. Post disaster, the treatment of physical illness typically takes precedence to the exclusion of preventive mental health measures. Even though the mental health effects of mass trauma are more pervasive and last longer than physical symptoms, mental health experts did not have a prominent place at the table of the COVID-19 response teams beyond their traditional role in the care of individual students. We conclude with a review of best practices for psychological first aid, and highlight the need for disaster response training for psychiatrists.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":"155-160"},"PeriodicalIF":5.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-01Epub Date: 2025-02-28DOI: 10.1007/s11920-025-01588-7
Karin Foerde
Purpose of review: Habits, characterized by automaticity and insensitivity to outcomes, may be key to the persistence of maladaptive behaviors in anorexia nervosa (AN). This review examines the status of habit research in AN, focusing on insights from task-based assessments.
Recent findings: Findings indicate dysfunction in the frontostriatal circuits associated with habitual and goal-directed behaviors, with some studies linking neural disturbances to habit measures or clinically relevant behaviors. Heightened habitual tendencies in AN have consistently been reported using self-reports, while research utilizing experimental paradigms has yielded mixed results and efforts to capture real-world habits in AN remain limited. Some experimental paradigms appear more sensitive than others, but all face challenges associated with studying habits in the lab. Promising new approaches will need to be adopted and efforts made to capture real-world habits. Understanding which habits are problematic, when in illness and for whom they dominate, could make good on the promise of habit-focused treatments for AN.
{"title":"Exploring Habits in Anorexia Nervosa: Promise, Pitfalls, and Progress.","authors":"Karin Foerde","doi":"10.1007/s11920-025-01588-7","DOIUrl":"10.1007/s11920-025-01588-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Habits, characterized by automaticity and insensitivity to outcomes, may be key to the persistence of maladaptive behaviors in anorexia nervosa (AN). This review examines the status of habit research in AN, focusing on insights from task-based assessments.</p><p><strong>Recent findings: </strong>Findings indicate dysfunction in the frontostriatal circuits associated with habitual and goal-directed behaviors, with some studies linking neural disturbances to habit measures or clinically relevant behaviors. Heightened habitual tendencies in AN have consistently been reported using self-reports, while research utilizing experimental paradigms has yielded mixed results and efforts to capture real-world habits in AN remain limited. Some experimental paradigms appear more sensitive than others, but all face challenges associated with studying habits in the lab. Promising new approaches will need to be adopted and efforts made to capture real-world habits. Understanding which habits are problematic, when in illness and for whom they dominate, could make good on the promise of habit-focused treatments for AN.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":"176-186"},"PeriodicalIF":5.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11922987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143522896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-27DOI: 10.1007/s11920-025-01606-8
Anastasia K Yocum, Balwinder Singh
<p><p>Bipolar Disorder (BD) is a chronic mental health condition characterized by significant mood swings, including periods of mania or hypomania and depression. Affecting approximately 1-2% of the global population, BD is associated with impaired social functioning, decreased quality of life, and an increased risk of suicide. The disorder presents a substantial burden on healthcare systems and imposes significant economic costs due to lost productivity and the need for extensive treatment and support services. This comprehensive review synthesizes global trends in BD pharmacotherapy over the past 1 to 3 years, focusing on emerging medications, novel treatment protocols, and ongoing debates within the field. Additionally, the review explores differences in prescribing patterns across developed and developing countries, introduces the impact of pharmacogenomics and personalized medicine on treatment outcomes. PURPOSE OF REVIEW: The primary purpose of this review is to provide a comprehensive and up-to-date synthesis of the global trends in the use of medications for the treatment of BD over the past 1 to 3 years. This review aims to outline the latest studies, clinical trials, and meta-analyses relevant to BD pharmacotherapy, highlighting new discoveries and advancements. Furthermore, this review will address ongoing debates and controversies in the field, such as the role of antidepressants in BD treatment and the long-term use of antipsychotics, aiming to bridge knowledge gaps and guide future research directions. RECENT FINDINGS: Studies continue to reinforce the efficacy of lithium in mood stabilization and reduction of suicidal behavior, despite its declining use due to safety concerns. Mood stabilizing anticonvulsants like valproate and carbamazepine continue to be vital alternatives, each with distinct side effect profiles necessitating careful patient monitoring. The approval and increasing use of novel atypical antipsychotics, such as lurasidone (2013) and cariprazine (2015), has expanded treatment options, offering efficacy in different phases of BD with relatively favorable side effect profiles. Antidepressants remain contentious, with evidence suggesting their benefits primarily when used in combination with mood stabilizers. Emerging agents like lumateperone (Dec 2021) and esketamine show promise, while pharmacogenomic research is paving the way for more personalized treatments. The landscape of BD pharmacotherapy is marked by significant advancements and ongoing challenges. Lithium and mood stabilizing anticonvulsants remain foundational treatments, albeit with adherence challenges and side effect concerns. The advent of new atypical antipsychotics and novel agents offers promising therapeutic options, while antidepressants continue to be debated. Personalized medicine and pharmacogenomics could emerge as transformative approaches, allowing for more tailored and effective treatments. However, disparities in medication accessibility
{"title":"Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder.","authors":"Anastasia K Yocum, Balwinder Singh","doi":"10.1007/s11920-025-01606-8","DOIUrl":"https://doi.org/10.1007/s11920-025-01606-8","url":null,"abstract":"<p><p>Bipolar Disorder (BD) is a chronic mental health condition characterized by significant mood swings, including periods of mania or hypomania and depression. Affecting approximately 1-2% of the global population, BD is associated with impaired social functioning, decreased quality of life, and an increased risk of suicide. The disorder presents a substantial burden on healthcare systems and imposes significant economic costs due to lost productivity and the need for extensive treatment and support services. This comprehensive review synthesizes global trends in BD pharmacotherapy over the past 1 to 3 years, focusing on emerging medications, novel treatment protocols, and ongoing debates within the field. Additionally, the review explores differences in prescribing patterns across developed and developing countries, introduces the impact of pharmacogenomics and personalized medicine on treatment outcomes. PURPOSE OF REVIEW: The primary purpose of this review is to provide a comprehensive and up-to-date synthesis of the global trends in the use of medications for the treatment of BD over the past 1 to 3 years. This review aims to outline the latest studies, clinical trials, and meta-analyses relevant to BD pharmacotherapy, highlighting new discoveries and advancements. Furthermore, this review will address ongoing debates and controversies in the field, such as the role of antidepressants in BD treatment and the long-term use of antipsychotics, aiming to bridge knowledge gaps and guide future research directions. RECENT FINDINGS: Studies continue to reinforce the efficacy of lithium in mood stabilization and reduction of suicidal behavior, despite its declining use due to safety concerns. Mood stabilizing anticonvulsants like valproate and carbamazepine continue to be vital alternatives, each with distinct side effect profiles necessitating careful patient monitoring. The approval and increasing use of novel atypical antipsychotics, such as lurasidone (2013) and cariprazine (2015), has expanded treatment options, offering efficacy in different phases of BD with relatively favorable side effect profiles. Antidepressants remain contentious, with evidence suggesting their benefits primarily when used in combination with mood stabilizers. Emerging agents like lumateperone (Dec 2021) and esketamine show promise, while pharmacogenomic research is paving the way for more personalized treatments. The landscape of BD pharmacotherapy is marked by significant advancements and ongoing challenges. Lithium and mood stabilizing anticonvulsants remain foundational treatments, albeit with adherence challenges and side effect concerns. The advent of new atypical antipsychotics and novel agents offers promising therapeutic options, while antidepressants continue to be debated. Personalized medicine and pharmacogenomics could emerge as transformative approaches, allowing for more tailored and effective treatments. However, disparities in medication accessibility ","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143718117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-20DOI: 10.1007/s11920-025-01602-y
Lee Anna Clark
Purpose of review: Provide an overview of the Alternative DSM-5 model of Personality Disorder (AMPD) and ICD-11's PD diagnostic model; review the models' assessment measures and construct validity; describe the models' current and ongoing status.
Recent findings: The models have many content similarities but differ significantly in that maladaptive-range traits are an AMPD requirement, but optional specifiers in ICD-11. An extensive literature using the Personality Inventory for DSM-5 (PID-5) has yielded comprehensive reviews of its clinical utility and construct validity. Structural meta-analyses found three core facets for each of the five domains, and correlations with non-FFM measures identified 13 traits with maladaptive content not assessed by the PID-5. Joint analyses of AMPD personality-functioning measures find a clear general factor, but have raised concerns about discriminant validity among measures and with Criterion B. For both criteria, the multimethod assessment literature is sparce. Regarding ICD-11, few measures assess the required personality functioning, but one has shown promising construct validity. Multiple measures assess the optional trait specifiers, the most noteworthy of which was developed by an international group, exists in 12 languages, and assesses all six domains of the DSM-5 and ICD-11.
Conclusion: The status of the ongoing revision process for the AMPD is described. It seems likely-but far from guaranteed-to result in a dimensional model in the main DSM-5 section. The next step for the ICD-11 is development of a version with Research Diagnostic Criteria, but the timeline is unknown.
{"title":"Wherefrom and Whither PD? Recent Developments and Future Possibilities in DSM-5 and ICD-11 Personality Disorder Diagnosis.","authors":"Lee Anna Clark","doi":"10.1007/s11920-025-01602-y","DOIUrl":"https://doi.org/10.1007/s11920-025-01602-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Provide an overview of the Alternative DSM-5 model of Personality Disorder (AMPD) and ICD-11's PD diagnostic model; review the models' assessment measures and construct validity; describe the models' current and ongoing status.</p><p><strong>Recent findings: </strong>The models have many content similarities but differ significantly in that maladaptive-range traits are an AMPD requirement, but optional specifiers in ICD-11. An extensive literature using the Personality Inventory for DSM-5 (PID-5) has yielded comprehensive reviews of its clinical utility and construct validity. Structural meta-analyses found three core facets for each of the five domains, and correlations with non-FFM measures identified 13 traits with maladaptive content not assessed by the PID-5. Joint analyses of AMPD personality-functioning measures find a clear general factor, but have raised concerns about discriminant validity among measures and with Criterion B. For both criteria, the multimethod assessment literature is sparce. Regarding ICD-11, few measures assess the required personality functioning, but one has shown promising construct validity. Multiple measures assess the optional trait specifiers, the most noteworthy of which was developed by an international group, exists in 12 languages, and assesses all six domains of the DSM-5 and ICD-11.</p><p><strong>Conclusion: </strong>The status of the ongoing revision process for the AMPD is described. It seems likely-but far from guaranteed-to result in a dimensional model in the main DSM-5 section. The next step for the ICD-11 is development of a version with Research Diagnostic Criteria, but the timeline is unknown.</p>","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143662836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}